Shire PLC

LON100:SHP, Aug 20, 12:15 UTC FTSE 100 real-time data - Disclaimer Currency in GBP

Latest LON100:SHP News

News

Bbva Compass Bancshares Inc. Cuts Stake in Shire PLC (SHPG)

SHP

acquired a new stake in shares of Shire PLC during the second quarter worth about $761,000. Hedge funds and other institutional investors own 20.22% of the company’s stock. NGAM Advisors L.P. raised its stake in shares of Shire PLC by 1.5% in the second quarter. Cantor Fitzgerald set a $222.00 target price on Shire PLC and gave the company a “buy” rating in a research report on Saturday, July 1st. Shire PLC has an average rating of “Buy” and a consensus target price of $220.08. Shire PLC Company Profile.

Read Full Details

Topics:
  • Business
  • Health
  • Financial
News

Shire PLC (LON:SHP) Price Target Lowered to GBX 5,250 at Jefferies Group LLC

SHP

Citigroup Inc. reaffirmed a “buy” rating on shares of Shire PLC in a report on Wednesday, April 12th. Berenberg Bank reaffirmed a “buy” rating on shares of Shire PLC in a report on Wednesday, April 12th. Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. Shire PLC (LON SHP) traded down 2.75% during midday trading on Monday, hitting GBX 3764.50. The company had a trading volume of 2,171,107 shares.

Read Full Details

Topics:
  • Business
  • Financial
News

Shire PLC (SHPG) Hits New 12-Month Low at $147.70

SHP

The stock of Shire PLC (ADR) (NASDAQ:SHPG) earned "Buy" rating by RBC Capital Markets on Monday, July 10. Stifel Nicolaus initiated it with "Buy" rating and $230 target in Thursday, May 26 report. Cantor Fitzgerald maintained the stock with "Buy" rating in Tuesday, July 11 report. Now the shares of Allison Transmission Holdings, Inc . The stock rose 0.52% or $0.11 reaching $22.24 per share.

Read Full Details

Story Sources

clicklancashire.com
Topics:
  • Business
  • Health
  • Financial
News

Shire Earns “Overweight” Recommendation at J P Morgan Chase Co

SHP

August 18, 2017. Shire (LON:SHP)‘s had a “overweight” recommendation reiterated by financial stock experts at J P Morgan Chase & Co in a study published on Thurs, Jul 20th. Shire Earns “Overweight” Recommendation at J P Morgan Chase Co. Barclays restated an “overweight” recommendation and fixed a GBX 6,500 ($84.38) target price on stock of Shire in a note on Fri, May 19th. Deutsche Bank AG restated a “buy” recommendation and fixed a GBX 6,100 ($79.19) target price on stock of Shire in a note on Fri, May 19th.

Read Full Details

Story Sources

insidertradings.org
Topics:
  • Business
  • Financial
News

Shire PLC 2017 Q2 - Results - Earnings Call Slides - Shire PLC (NASDAQ:SHPG)

SHP

Shire PLC 2017 Q2 - Results - Earnings Call Slides. The following slide deck was published by Shire PLC in conjunction with their 2017 Q2 earnings call.

Read Full Details

Story Sources

seekingalpha.com
Topics:
  • Business
  • Financial
News

Orbimed Advisors Has Lifted Shire Plc (SHPG) Holding By $23.80 Million; 4 Analysts Are Bullish KUKA AG (ETR:KU2) Last Week

SHP

Orbimed Advisors Llc acquired 140,000 shares as Shire Plc (SHPG)’s stock rose 4.45%. Orbimed Advisors Has Lifted Shire Plc (SHPG) Holding By $23.80 Million; Commerzbank maintained KUKA AG (ETR:KU2) on Wednesday, June 1 with “Hold” rating. HSBC maintained KUKA AG (ETR:KU2) rating on Wednesday, September 14. HSBC has “Hold” rating and €75 target.

Read Full Details

Story Sources

whatsonthorold.com
Topics:
  • Business
  • Financial
News

Highline Capital Management Has Trimmed Shire Plc (SHPG) Holding; Bank Of Nova Scotia Has Upped Bce (BCE) Holding

SHP

Bank Of Nova Scotia acquired 5.33M shares as Bce Inc (BCE)’s stock declined 0.38%. Highline Capital Management Llc sold 311,900 shares as Shire Plc (SHPG)’s stock rose 4.45%. As per Friday, October 16, the company rating was upgraded by RBC Capital Markets. The stock of BCE Inc. (USA) (NYSE:BCE) earned “Neutral” rating by Credit Suisse on Monday, January 4. As per Tuesday, March 21, the company rating was maintained by Barclays Capital.

Read Full Details

Story Sources

whatsonthorold.com
Topics:
  • Business
  • Financial
  • Entertainment
News

Toronto Dominion Bank Upped Its American International Group (AIG) Holding; Bridger Management Has Raised Shire Plc (SHPG) Position

SHP AIG

Toronto Dominion Bank acquired 139,555 shares as American International Group Inc (AIG)’s stock declined 2.08%. Bridger Management Llc acquired 135,562 shares as Shire Plc (SHPG)’s stock rose 4.45%. Sunbelt Secs has 0% invested in American International Group Inc (NYSE:AIG) for 818 shares. Moreover, Markston Limited Liability Corporation has 1% invested in American International Group Inc (NYSE:AIG) for 161,802 shares.

Read Full Details

Story Sources

whatsonthorold.com
Topics:
  • Business
  • Financial
News

Cholestasis - Pharmaceutical & Healthcare disease Clinical Trials Review, H1, 2017 Mentioning Key Vendors Shire Plc, Albireo Pharma Inc, Abbott Laboratories

SHP

This report provides top line data relating to the clinical trials on Cholestasis. Cholestasis - Pharmaceutical & Healthcare disease Clinical Trials Review, H1, 2017 Mentioning Key Vendors Shire Plc, Albireo Pharma Inc, Abbott Laboratories. Buy this report @ https://www. Get customization & check discount for report @ https://www.

Read Full Details

Story Sources

medgadget.com
Topics:
  • Business
  • Health
  • Financial
  • Science
News

Shire plc - American Depositary (SHPG) Position Increased by Afam Capital, Inc. - Modern Readers

SHP

Afam Capital, Inc. says it increased its ownership in Shire plc – American Depositary by 8.8% as of the end of the last quarter. Shire plc - American Depositary (SHPG) Position Increased by Afam Capital, Inc. Shire plc – American Depositary (NASDAQ:SHPG). The value of the investment in Shire plc – American Depositary decreased from $21,224,000 to $2,495,000 decreasing 88.2% quarter over quarter. The value of the company’s investment in Shire plc – American Depositary went from $193,200,000 to $151,450,000 a change of 21.6% since the last quarter.

Read Full Details

Story Sources

modernreaders.com
Topics:
  • Business
  • Financial
News

Shire PLC (SHP) Receives Overweight Rating from J P Morgan Chase & Co

SHP

Liberum Capital reiterated a “buy” rating and issued a GBX 5,500 ($71.40) price target on shares of Shire PLC in a research note on Monday, April 10th. Finally, Deutsche Bank AG reiterated a “buy” rating and issued a GBX 6,100 ($79.19) price target on shares of Shire PLC in a research note on Friday, May 19th. Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. In other Shire PLC news, insider Dominic Blakemore purchased 152 shares of the company’s stock in a transaction that occurred on Friday, June 30th.

Read Full Details

Topics:
  • Business
  • Financial
News

Everett Harris & Co. CA Has $1.12 Million Stake in Shire PLC (SHPG) - Markets Daily

SHP

boosted its stake in shares of Shire PLC by 18.2% in the first quarter. Profund Advisors LLC boosted its stake in shares of Shire PLC by 4.1% in the first quarter. Finally, ValuEngine cut shares of Shire PLC from a “buy” rating to a “hold” rating in a research note on Friday, June 2nd. Royal Bank Of Canada set a $221.00 price objective on shares of Shire PLC and gave the stock a “buy” rating in a research note on Thursday, May 18th.

Read Full Details

Story Sources

themarketsdaily.com
Topics:
  • Business
  • Health
  • Financial
News

AT Bancorp Cuts Position in Shire PLC (SHPG)

SHP

Inspirion Wealth Advisors LLC now owns 1,944 shares of the biopharmaceutical company’s stock worth $321,000 after buying an additional 8 shares during the last quarter. Dumont & Blake Investment Advisors LLC now owns 2,594 shares of the biopharmaceutical company’s stock valued at $452,000 after buying an additional 7 shares in the last quarter. Cowen and Company restated an “outperform” rating and issued a $325.00 target price on shares of Shire PLC in a research report on Wednesday, May 31st. The company has a consensus rating of “Buy” and an average price target of $220.08. About Shire PLC.

Read Full Details

Topics:
  • Business
  • Health
  • Financial
News

Shire PLC (SHPG) Shares Sold by Janney Montgomery Scott LLC - Markets Daily

SHP

boosted its stake in shares of Shire PLC by 14.9% in the first quarter. boosted its stake in shares of Shire PLC by 2.2% in the fourth quarter. Royal Bank Of Canada set a $221.00 target price on shares of Shire PLC and gave the company a “buy” rating in a research report on Thursday, May 18th. Finally, Stifel Nicolaus dropped their target price on shares of Shire PLC from $250.00 to $245.00 and set a “buy” rating for the company in a research report on Friday, June 9th.

Read Full Details

Story Sources

themarketsdaily.com
Topics:
  • Business
  • Health
  • Financial
News

Shire PLC (SHPG) Receives Media Sentiment Rating of 0.18

SHP

Media stories about Shire PLC (NASDAQ:SHPG) have been trending somewhat positive this week, according to Accern Sentiment Analysis. On average, analysts forecast that Shire PLC will post $14.92 earnings per share for the current fiscal year. Finally, ValuEngine lowered shares of Shire PLC from a “buy” rating to a “hold” rating in a research note on Friday, June 2nd. Royal Bank Of Canada set a $221.00 price target on shares of Shire PLC and gave the company a “buy” rating in a research note on Thursday, May 18th.

Read Full Details

Topics:
  • Business
  • Financial
News

Shire PLC (SHPG) Reaches New 1-Year Low at $156.11

SHP

Cantor Fitzgerald set a $222.00 price target on shares of Shire PLC and gave the company a “buy” rating in a report on Saturday, July 1st. Cantor Fitzgerald set a $222.00 price objective on shares of Shire PLC and gave the stock a “buy” rating in a report on Saturday, July 1st. Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. Inc. increased its position in shares of Shire PLC by 3.1% in the first quarter.

Read Full Details

Topics:
  • Business
  • Health
  • Financial
News

Shire PLC (LON:SHP) Price Target Cut to GBX 5,250 - Week Herald

SHP

Deutsche Bank AG reaffirmed a “buy” rating and set a GBX 6,000 ($77.89) price target on shares of Shire PLC in a research report on Friday, August 4th. Credit Suisse Group reaffirmed an “outperform” rating and set a GBX 5,350 ($69.45) price target on shares of Shire PLC in a research report on Friday, August 4th. Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. In related news, insider Dominic Blakemore bought 152 shares of the company’s stock in a transaction dated Friday, June 30th.

Read Full Details

Topics:
  • Business
  • Financial
News

Atlas Copco: Top of the Street: QinetiQ, Atlas Copco, Maersk, Shire

SHP

** Following the stock's decline Barclays upgrades QinetiQ to "overweight", believing that the balance of risk/reward is now favorably skewed. ** Evercore initiates Shire with "outperform", claiming that the key biologic franchises are well positioned for growth to offset hemophilia decline. (c) Copyright Thomson Reuters 2017. Click For Restrictions - http://about. More From The Times of India.

Read Full Details

Topics:
  • Business
  • Financial
News

Shire PLC’s (SHP) Long Term Buy Rating Reaffirmed at Beaufort Securities

SHP

Deutsche Bank AG reissued a “buy” rating and set a GBX 6,100 ($79.19) price objective on shares of Shire PLC in a report on Friday, May 19th. Finally, Citigroup Inc. reissued a “buy” rating and set a GBX 6,500 ($84.38) price objective on shares of Shire PLC in a report on Wednesday, May 17th. Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. Shire PLC presently has a consensus rating of “Buy” and a consensus price target of GBX 5,907.88 ($76.70).

Read Full Details

Topics:
  • Business
  • Financial
News

Shire PLC (SHP) Earns Outperform Rating from Credit Suisse Group

SHP

Finally, Deutsche Bank AG restated a buy rating and set a GBX 6,100 ($79.19) price target on shares of Shire PLC in a research report on Friday, May 19th. Liberum Capital restated a buy rating and set a GBX 5,500 ($71.40) price target on shares of Shire PLC in a research report on Monday, April 10th. Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The ex-dividend date of this dividend is Thursday, September 7th.

Read Full Details

Topics:
  • Business
  • Financial